Release of tissue plasminogen activator and its fast-acting inhibitor in defective fibrinolysis
- 1 January 1986
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 146 (1) , 188-191
- https://doi.org/10.1001/archinte.146.1.188
Abstract
Releasable tissue plasminogen activator (t-PA) and the fast inhibitor of t-PA were measured in 18 controls and a pedigree with venous thrombosis. The functional assay was performed by a technique that destroys the t-PA inhibitor when blood is drawn. It was found that activator and inhibitor levels varied widely in the control group. One patient demonstrated inhibitor levels, on two different occasions, of 2.82 and 3.54 IU of t-PA per milliliter of plasma, as compared with a releasable activator level of 1.87 IU/mL. The t-PA antigen levels of this patient and the remainder of the pedigree were essentially normal for all seven subjects. Thus, it is suggested that the previously reported fibrinolytic disorder in this pedigree represents an imbalance between activator and inhibitor levels rather than an actual deficiency of t-PA. (Arch Intern Med1986;146:188-191)This publication has 13 references indexed in Scilit:
- Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditionsThrombosis Research, 1984
- Evidence for a rapid inhibitor to tissue plasminogen activator in plasmaThrombosis Research, 1983
- MEASUREMENT OF HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR BY A 2-SITE IMMUNORADIOMETRIC ASSAY1983
- Venous thrombosis in a family with defective release of vascular plasminogen activator and elevated plasma factor VIII/von Willebrand's factorThe American Journal of Medicine, 1983
- DEFICIENCIES OF PROTEIN C, AN INHIBITOR OF BLOOD COAGULATIONThe Lancet, 1982
- A colorimetric assay for releasable plasminogen activator.Clinical Chemistry, 1982
- Protein C Deficiency in a Dutch Family with Thrombotic DiseaseThrombosis and Haemostasis, 1982
- Deficiency of protein C in congenital thrombotic disease.Journal of Clinical Investigation, 1981
- A LYSINE-ADSORBABLE PLASMINOGEN-ACTIVATOR IS ELEVATED IN CONDITIONS ASSOCIATED WITH INCREASED FIBRINOLYTIC-ACTIVITY1981
- A study of proteases and protease-inhibitor complexes in biological fluidsThe Journal of Experimental Medicine, 1978